BioLineRx Ltd. Increase Decrease Through Share-based Payment Transactions
BioLineRx Ltd. (BLRX) reported Increase Decrease Through Share-based Payment Transactions of $396.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2026-03-23
- BioLineRx Ltd. increase decrease through share-based payment transactions for the quarter ending 2022-06-30 was $330.00K, a 8.59% decline year-over-year.
- BioLineRx Ltd. increase decrease through share-based payment transactions for the quarter ending 2021-06-30 was $361.00K, a 39.38% increase year-over-year.
- BioLineRx Ltd. increase decrease through share-based payment transactions for the quarter ending 2020-06-30 was $259.00K, a 47.03% decline year-over-year.
- BioLineRx Ltd. increase decrease through share-based payment transactions for the quarter ending 2019-06-30 was $489.00K.
| Period end | Increase Decrease Through Share-based Payment Transactions 3 month | Increase Decrease Through Share-based Payment Transactions 6 month | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|---|---|
| 2025-12-31 | $396.00K 20-F · filed 2026-03-23 | ||
| 2025-06-30 | $247.00K 6-K · filed 2025-08-14 | ||
| 2024-12-31 | $1.14M 20-F · filed 2026-03-23 | ||
| 2024-06-30 | $1.04M 6-K · filed 2025-08-14 | ||
| 2023-12-31 | $2.32M 20-F · filed 2026-03-23 | ||
| 2023-06-30 | $920.00K 6-K · filed 2024-08-15 | ||
| 2022-12-31 | $2.25M 20-F · filed 2025-03-31 | ||
| 2022-06-30 | $330.00K 6-K · filed 2022-08-16 | $586.00K 6-K · filed 2023-08-30 | |
| 2021-12-31 | $1.50M 20-F · filed 2024-03-26 | ||
| 2021-06-30 | $361.00K 6-K · filed 2022-08-16 | $832.00K 6-K · filed 2022-08-16 | |
| 2020-12-31 | $1.27M 20-F · filed 2023-03-22 | ||
| 2020-06-30 | $259.00K 6-K · filed 2021-08-18 | $922.00K 6-K · filed 2021-08-18 | |
| 2019-12-31 | $1.76M 20-F · filed 2022-03-16 | ||
| 2019-06-30 | $489.00K 6-K · filed 2020-08-06 | $773.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $2.53M 20-F · filed 2021-02-23 | ||
| 2018-06-30 | $1.44M 6-K · filed 2019-08-06 | ||
| 2017-12-31 | $1.51M 20-F · filed 2020-03-12 | ||
| 2017-06-30 | $858.00K 6-K · filed 2018-08-13 | ||
| 2016-12-31 | $1.07M 20-F · filed 2019-03-28 | ||
| 2015-12-31 | $1.15M 20-F · filed 2018-03-06 |